Number of entries related to HSC-3 cell line is 21 GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 27002147
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qPCR and SFA | NA | 0.28 | 0.5461 | 26448762
| NANOG | 20857 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qRT-PCR followed by CFA | NA | 0.28 | 0.5461 | 22847005
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 27002147
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qPCR and SFA | NA | 0.28 | 0.6448 | 26448762
| POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qRT-PCR followed by CFA | NA | 0.28 | 0.6448 | 22847005
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 27002147
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qPCR and SFA | NA | 0.28 | 0.5695 | 26448762
| SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qRT-PCR followed by CFA | NA | 0.28 | 0.5695 | 22847005
| KLF4 | 6348 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | qPCR and SFA | NA | 0.2 | 0.0891 | 26448762
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | ALDEFLUOR assay | NA | 0.12 | 0.684 | 29515788
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | ALDEFLUOR assay followed by CFA | NA | 0.12 | 0.684 | 22847005
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | ALDEFLUOR assay followed by SFA | NA | 0.12 | 0.684 | 26448762
| ALDH1A1 | 402 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs followed by SFA | NA | 0.12 | 0.684 | 27002147
| CD24 | 1645 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs | NA | 0.12 | 0.456 | 30029671
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs | NA | 0.12 | 1 | 29515788
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs followed by CFA | NA | 0.12 | 1 | 22847005
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs followed by SFA | NA | 0.12 | 1 | 26448762
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs followed by SFA | NA | 0.12 | 1 | 27002147
| CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs | NA | 0.12 | 1 | 30029671
| ITGB1 | 6153 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | HSC-3 | NA | FACs | NA | 0.12 | 0.018 | 30029671
|
|